Now showing items 1-3 of 3

  • 175 years of bilirubin testing : ready for point-of-care? 

    Guirguis, Natalie; Bertrand, Antoine-Xavier; Rose, Christopher; Matoori, Simon (Wiley, 2023-04-10)
    Bilirubin was first detected in blood in 1847 and since then has become one of the most widely used biomarkers for liver disease. Clinical routine bilirubin testing is performed at the hospital laboratory, and the gold standard colorimetric test is ...
  • Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel 

    Samman, Karla N.; Mehanna, Pamela; Takla, Emad; Grenier, Jean-Christophe; Chan, Mark Y.; Lopes, Renato D.; Neely, Megan Lee; Wang, Tracy Y.; Newby, L. Kristin; Becker, Richard C.; Lordkipanidzé, Marie; Ruiz, Matthieu; Hussin, Julie; Jolicœur, Marc (Cell press, 2021-06-04)
    Untargeted metabolomics is used to refine the development of biomarkers for the diagnosis of cardiovascu-lar disease. Myocardial infarction (MI) has major individual and societal consequences for patients, whoremain at high risk of secondary events, ...
  • Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats 

    Servonnet, Alice; Allain, Florence; Gravel-Chouinard, Alice; Hernandez, Giovanni; Bourdeau Caporuscio, Casey; Legrix, Mathilde; Lévesque, Daniel; Rompré, Pierre-Paul; Samaha, Anne-Noël (Elsevier, 2021-08-05)
    Antipsychotic treatment can produce a dopamine-supersensitive state, potentiating the response to dopamine receptor stimulation. In both schizophrenia patients and rats, this is linked to tolerance to ongoing antipsychotic treatment. In rodents, dopamine ...